Necrotizing Granulomatous Hypophysitis Presenting as a Sellar Mass

2011 ◽  
Vol 22 (1) ◽  
pp. 6-9 ◽  
Author(s):  
Sahar Al-Haddad ◽  
Rafael Fandino ◽  
Bernd W. Scheithauer ◽  
Leandro Galvis ◽  
Luis V. Syro ◽  
...  
1989 ◽  
Vol 71 (5) ◽  
pp. 681-686 ◽  
Author(s):  
Massimo Scanarini ◽  
Domenico d'Avella ◽  
Antonino Rotilio ◽  
Nicolaos Kitromilis ◽  
Salvatore Mingrino

✓ Idiopathic giant-cell granulomatous hypophysitis is a chronic inflammatory disorder of the pituitary gland. It presents clinically as a sellar mass lesion with pituitary insufficiency and/or hyperprolactinemia, and is radiologically indistinguishable from a pituitary tumor. In most of the previously reported cases the documentation of the disorder has been limited to autopsy tissue. Only a few cases documented by biopsy have been recorded. Four cases are presented here with radiological, endocrinological, and surgical findings. The appropriately documented cases collected from the literature and the present series are reviewed and the incidence, patterns of clinical and radiological presentation, and operative management of this disorder are discussed. This entity should be considered when evaluating patients with a pituitary mass and evidence of hypopituitarism and hyperprolactinemia.


2019 ◽  
Author(s):  
Sema Ciftci Dogansen ◽  
Omur Gunaldi ◽  
Osman Tanrıverdi ◽  
Ilkay Cakir ◽  
Meral Mert

1997 ◽  
Vol 39 (1) ◽  
pp. 7-11 ◽  
Author(s):  
M. Vasile ◽  
K. Marsot-Dupuch ◽  
M. Kujas ◽  
L. Brunereau ◽  
P. Bouchard ◽  
...  

2006 ◽  
Vol 26 (1) ◽  
pp. 49-50 ◽  
Author(s):  
Saiju Jacob ◽  
Eleanor Pye ◽  
Majed Hbahbih ◽  
Nicholas Messios ◽  
Yusuf A Rajabally

Author(s):  
Merve Meryem Kiran ◽  
Ercan Bal ◽  
Ayca Dilsad Kuratmer ◽  
Karabekir Ercan ◽  
Berrak Gumuskaya ◽  
...  

Author(s):  
Alexander T. Faje ◽  
Nicholas A. Tritos
Keyword(s):  

Author(s):  
Matthew Seymour ◽  
Thomas Robertson ◽  
Jason Papacostas ◽  
Kirk Morris ◽  
Jennifer Gillespie ◽  
...  

Summary A 34-year-old woman presented 18 months post-partum with blurred vision, polyuria, amenorrhoea, headache and general malaise. Comprehensive clinical examination showed left superior temporal visual loss only. Initial investigations revealed panhypopituitarism and MRI demonstrated a sellar mass involving the infundibulum and hypothalamus. Lymphocytic hypophysitis was suspected and high dose glucocorticoids were commenced along with desmopressin and thyroxine. However, her vision rapidly deteriorated. At surgical biopsy, an irresectable grey amorphous mass involving the optic chiasm was identified. Histopathology was initially reported as granulomatous hypophysitis. Despite the ongoing treatment with glucocorticoids, her vision worsened to light detection only. Histopathological review revised the diagnosis to partially treated lymphoma. A PET scan demonstrated avid uptake in the pituitary gland in addition to splenic involvement, lymphadenopathy above and below the diaphragm, and a bone lesion. Excisional node biopsy of an impalpable infraclavicular lymph node confirmed nodular lymphocyte-predominant Hodgkin lymphoma. Hyper-CVAD chemotherapy was commenced, along with rituximab; fluid-balance management during chemotherapy (with its requisite large fluid volumes) was extremely complex given her diabetes insipidus. The patient is now in clinical remission. Panhypopituitarism persists; however, her vision has recovered sufficiently for reading large print and driving. To the best of our knowledge, this is the first reported case of Hodgkin lymphoma presenting initially as hypopituitarism. Learning points Lymphoma involving the pituitary is exceedingly rare and, to the best of our knowledge, this is the first reported case of nodular lymphocyte-predominant Hodgkin lymphoma presenting as hypopituitarism. There are myriad causes of a sellar mass and this case highlights the importance of reconsidering the diagnosis when patients fail to respond as expected to appropriate therapeutic intervention. This case highlights the difficulties associated with managing panhypopituitary patients receiving chemotherapy, particularly when this involves large volumes of i.v. hydration fluid.


Sign in / Sign up

Export Citation Format

Share Document